Plakoglobin represses SATB1 expression and decreases in Vitro proliferation, migration and invasion

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Aktary, Zackie ^a   Pasdar, Manijeh ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; PLAKOGLOBIN; SATB1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG TARGETING; GENE; GENE ACTIVITY; GENE CONTROL; GENE REPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PROMOTER REGION; PROTEIN FUNCTION; SATB1 GENE; TONGUE CARCINOMA; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DESMOPLAKINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS;

EID: 84892575279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078388     Document Type: Article

References (95)

1. Jeanes A, Gottardi CJ, Yap AS (2008) Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27: 6920-6929.
2. Makrilia N, Kollias A, Manolopoulos L, Syrigos K (2009) Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 27: 1023-1037.
3. Yilmaz M, Christofori G (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8: 629-642.
4. Saito M, Tucker DK, Kohlhorst D, Niessen CM, Kowalczyk AP (2012) Classical and desmosomal cadherins at a glance. J Cell Sci 125: 2547-2552.
5. Nelson WJ, Dickinson DJ, Weis WI. (2013) Roles of cadherins and catenins in cell-cell adhesion and epithelial cell polarity. Prog Mol Biol Transl Sci 116: 3-23.
6. Yonemura S (2011) Cadherin-actin interactions at adherens junctions. Curr Opin Cell Biol 23: 515-522.
7. Kowalczyk AP, Green KJ (2013) Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci 116: 95-118.
8. Peifer M, McCrea PD, Green KJ, Wieschaus E, Gumbiner BM (1992) The vertebrate adhesive junction proteins beta-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties. J Cell Biol 118: 681-691.
9. Zhurinsky J, Shtutman M, Ben-Ze'ev A (2000a) Plakoglobin and beta-catenin: protein interactions, regulation and biological roles. J Cell Sci 113 (Pt 18): 3127-3139.
10. Aktary Z, Pasdar M (2012) Plakoglobin: role in tumorigenesis and metastasis. Int J Cell Biol 2012: 189521.
11. Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, et al. (1998) Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. J Cell Biol 141: 1433-1448.
12. Zhurinsky J, Shtutman M, Ben-Ze'ev A (2000b) Differential mechanisms of LEF/TCF family-dependent transcriptional activation by beta-catenin and plakoglobin. Mol Cell Biol 20: 4238-4252.
13. Miravet S, Piedra J, Miro F, Itarte E, Garcia de Herreros A, et al. (2002) The transcriptional factor TCF-4 contains different binding sites for beta-catenin and plakoglobin. J Biol Chem 277: 1884-1891.
14. Aktary Z, Kulak S, Mackey J, Jahroudi N, Pasdar M (2013) Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3sigma. J Cell Sci 126: 3031-3042.
15. Parker HR, Li Z, Sheinin H, Lauzon G, Pasdar M (1998) Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin. Cell Motil Cytoskeleton 40: 87-100.
16. Winn RA, Bremnes RM, Bemis L, Franklin WA, Miller YE, et al. (2002) gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 21: 7497-7506.
17. Rieger-Christ KM, Ng L, Hanley RS, Durrani O, Ma H, et al. (2005) Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential. Br J Cancer 92: 2153-2159.
18. Yin T, Getsios S, Caldelari R, Kowalczyk AP, Muller EJ, et al. (2005) Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 102: 5420-5425.
19. Aktary Z, Chapman K, Lam L, Lo A, Ji C, et al. (2010) Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1. Oncogene 29: 2118-2129.
20. Bailey CK, Mittal MK, Misra S, Chaudhuri G (2012) High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG. J Biol Chem 287: 19472-19486.
21. Franzen CA, Todorovic V, Desai BV, Mirzoeva S, Yang XJ, et al. (2012) The desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signaling. PLoS One 7: e42132.
22. Kim W, Kim M, Jho EH (2013) Wnt/beta-catenin signalling: from plasma membrane to nucleus. Biochem J 450: 9-21.
23. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T (1992) A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70: 631-645.
24. de Belle I, Cai S, Kohwi-Shigematsu T (1998) The genomic sequences bound to special AT-rich sequence-binding protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated with the nuclear matrix at the bases of the chromatin loops. J Cell Biol 141: 335-348.
25. Kohwi-Shigematsu T, Kohwi Y (1990) Torsional stress stabilizes extended base unpairing in suppressor sites flanking immunoglobulin heavy chain enhancer. Biochemistry 29: 9551-9560.
26. Kohwi-Shigematsu T, Poterlowicz K, Ordinario E, Han HJ, Botchkarev VA, et al. (2013) Genome organizing function of SATB1 in tumor progression. Semin Cancer Biol 23: 72-79.
27. Bode J, Kohwi Y, Dickinson L, Joh T, Klehr D, et al. (1992) Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science 255: 195-197.
28. Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34: 42-51.
29. Cai S, Lee CC, Kohwi-Shigematsu T (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278-1288.
30. Kumar PP, Bischof O, Purbey PK, Notani D, Urlaub H, et al. (2007) Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9: 45-56.
31. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641-645.
32. Kumar PP, Purbey PK, Ravi DS, Mitra D, Galande S (2005) Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol Cell Biol 25: 1620-1633.
33. Wen J, Huang S, Rogers H, Dickinson LA, Kohwi-Shigematsu T, et al. (2005) SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 105: 3330-3339.
34. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T (2008) SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452: 187-193.
35. Li QQ, Chen ZQ, Xu JD, Cao XX, Chen Q, et al. (2010) Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci 101: 80-86.
36. Zhao XD, Ji WY, Zhang W, He LX, Yang J, et al. (2010) Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 72: 1-5.
37. Chen H, Takahara M, Oba J, Xie L, Chiba T, et al. (2011) Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci 64: 39-44.
38. Xiang J, Zhou L, Li S, Xi X, Zhang J, et al. (2012) AT-rich sequence binding protein 1: Contribution to tumor progression and metastasis of human ovarian carcinoma. Oncol Lett 3: 865-870.
39. Tu W, Luo M, Wang Z, Yan W, Xia Y, et al. (2012) Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer. Liver Int 32: 1064-1078.
40. Nodin B, Hedner C, Uhlen M, Jirstrom K (2012) Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer. J Ovarian Res 5: 24.
41. Chu SH, Ma YB, Feng DF, Li ZQ, Jiang PC (2012) Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. Mol Med Rep.
42. Huang B, Zhou H, Wang X, Liu Z (2013) Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cells. Cancer Cell Int 13: 8.
43. Ramakrishnan M, Liu WM, DiCroce PA, Posner A, Zheng J, et al. (2000) Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2. Mol Cell Biol 20: 868-877.
44. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, et al. (2010) Global regulator SATB1 recruits beta-catenin and regulates T (H)2 differentiation in Wnt-dependent manner. PLoS Biol 8: e1000296.
45. Lam L, Hu X, Aktary Z, Andrews DW, Pasdar M (2009) Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha. Breast Cancer Res Treat 118: 605-621.
46. Peng Y, Jahroudi N (2003) The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J Biol Chem 278: 8385-8394.
47. Lei L, Lu L, Xiang L, Xue-song W, De-pei L, et al. (2010) Epigenetic repression of SATB1 by polycomb group protein EZH2 in epithelial cells. Chin Med Sci J 25: 199-205.
48. Qu S, Long J, Cai Q, Shu XO, Cai H, et al. (2008) Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival. Clin Cancer Res 14: 4787-4793.
49. Lam L, Aktary Z, Bishay M, Werkman C, Kuo CY, et al. (2012) Regulation of subcellular distribution and oncogenic potential of nucleophosmin by plakoglobin. Oncogenesis 1: e4.
50. Alvarez JD, Yasui DH, Niida H, Joh T, Loh DY, et al. (2000) The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev 14: 521-535.
51. Fessing MY, Mardaryev AN, Gdula MR, Sharov AA, Sharova TY, et al. (2011) p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol 194: 825-839.
52. Notani D, Ramanujam PL, Kumar PP, Gottimukkala KP, Kumar-Sinha C, et al. (2011) N-terminal PDZ-like domain of chromatin organizer SATB1 contributes towards its function as transcription regulator. J Biosci 36: 461-469.
53. Purbey PK, Singh S, Notani D, Kumar PP, Limaye AS, et al. (2009) Acetylation-dependent interaction of SATB1 and CtBP1 mediates transcriptional repression by SATB1. Mol Cell Biol 29: 1321-1337.
54. Burute M, Gottimukkala K, Galande S (2012) Chromatin organizer SATB1 is an important determinant of T-cell differentiation. Immunol Cell Biol 90: 852-859.
55. Zhang J, Ma C, Han X, Durrin LK, Sun Y (2006) The bcl-2 major breakpoint region (mbr) possesses transcriptional regulatory function. Gene 379: 127-131.
56. Ma C, Zhang J, Durrin LK, Lv J, Zhu D, et al. (2007) The BCL2 major breakpoint region (mbr) regulates gene expression. Oncogene 26: 2649-2657.
57. Li Q, Dashwood WM, Zhong X, Nakagama H, Dashwood RH (2007) Bcl-2 overexpression in PhIP-induced colon tumors: cloning of the rat Bcl-2 promoter and characterization of a pathway involving beta-catenin, c-Myc and E2F1. Oncogene 26: 6194-6202.
58. Li L, Chapman K, Hu X, Wong A, Pasdar M (2007) Modulation of the oncogenic potential of beta-catenin by the subcellular distribution of plakoglobin. Mol Carcinog 46: 824-838.
59. Salomon D, Sacco PA, Roy SG, Simcha I, Johnson KR, et al. (1997) Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J Cell Biol 139: 1325-1335.
60. Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, et al. (2006) Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J 25: 3298-3309.
61. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
62. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
63. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, et al. (1988) Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204.
64. Thakur RK, Yadav VK, Kumar P, Chowdhury S (2011) Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types. Naunyn Schmiedebergs Arch Pharmacol 384: 397-406.
65. Marino N, Nakayama J, Collins JW, Steeg PS (2012) Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene. Cancer Metastasis Rev 31: 593-603.
66. Wagner PD, Steeg PS, Vu ND (1997) Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci U S A 94: 9000-9005.
67. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO (2000) The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 32: 247-258.
68. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J (2003) Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112: 659-672.
69. Steeg PS, Horak CE, Miller KD (2008) Clinical-translational approaches to the Nm23-H1 metastasis suppressor. Clin Cancer Res 14: 5006-5012.
70. Novak M, Jarrett SG, McCorkle JR, Mellon I, Kaetzel DM (2011) Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma. Naunyn Schmiedebergs Arch Pharmacol 384: 433-438.
71. Postel EH, Berberich SJ, Flint SJ, Ferrone CA (1993) Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science 261: 478-480.
72. Postel EH, Berberich SJ, Rooney JW, Kaetzel DM (2000) Human NM23/ nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr 32: 277-284.
73. Ma D, Xing Z, Liu B, Pedigo NG, Zimmer SG, et al. (2002) NM23-H1 and NM23-H2 repress transcriptional activities of nuclease-hypersensitive elements in the platelet-derived growth factor-A promoter. J Biol Chem 277: 1560-1567.
74. Postel EH (2003) Multiple biochemical activities of NM23/NDP kinase in gene regulation. J Bioenerg Biomembr 35: 31-40.
75. Cervoni L, Egistelli L, Eufemi M, d'Abusco AS, Altieri F, et al. (2006) DNA sequences acting as binding sites for NM23/NDPK proteins in melanoma M14 cells. J Cell Biochem 98: 421-428.
76. Thakur RK, Kumar P, Halder K, Verma A, Kar A, et al. (2009) Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression. Nucleic Acids Res 37: 172-183.
77. Choudhuri T, Murakami M, Kaul R, Sahu SK, Mohanty S, et al. (2010) Nm23-H1 can induce cell cycle arrest and apoptosis in B cells. Cancer Biol Ther 9: 1065-1078.
78. Lee HY, Lee H (1999) Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity. Cancer Lett 145: 93-99.
79. Khan MH, Yasuda M, Higashino F, Haque S, Kohgo T, et al. (2001) nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression. Am J Pathol 158: 1785-1791.
80. Suzuki E, Ota T, Tsukuda K, Okita A, Matsuoka K, et al. (2004) nm23-H1 reduces in vitro cell migration and the liver metastatic potential of colon cancer cells by regulating myosin light chain phosphorylation. Int J Cancer 108: 207-211.
81. Jung S, Paek YW, Moon KS, Wee SC, Ryu HH, et al. (2006) Expression of Nm23 in gliomas and its effect on migration and invasion in vitro. Anticancer Res 26: 249-258.
82. McDermott WG, Boissan M, Lacombe ML, Steeg PS, Horak CE (2008) Nm23-H1 homologs suppress tumor cell motility and anchorage independent growth. Clin Exp Metastasis 25: 131-138.
83. Kar A, Saha D, Purohit G, Singh A, Kumar P, et al. (2012) Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells. Nucleic Acids Res 40: 2554-2565.
84. Bago R, Pavelic J, Maravic Vlahovicek G, Bosnar MH (2009) Nm23-H1 promotes adhesion of CAL 27 cells in vitro. Mol Carcinog 48: 779-789.
85. Zhang Q, McCorkle JR, Novak M, Yang M, Kaetzel DM (2011) Metastasis suppressor function of NM23-H1 requires its 3′-5′ exonuclease activity. Int J Cancer 128: 40-50.
86. Jarrett SG, Novak M, Dabernat S, Daniel JY, Mellon I, et al. (2012) Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis. Cancer Res 72: 133-143.
87. Holen I, Whitworth J, Nutter F, Evans A, Brown HK, et al. (2012) Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo. Breast Cancer Res 14: R86.
88. Chen SL, Wu YS, Shieh HY, Yen CC, Shen JJ, et al. (2003) P53 is a regulator of the metastasis suppressor gene Nm23-H1. Mol Carcinog 36: 204-214.
89. Rahman-Roblick R, Roblick UJ, Hellman U, Conrotto P, Liu T, et al. (2007) p53 targets identified by protein expression profiling. Proc Natl Acad Sci U S A 104: 5401-5406.
90. Tokonzaba E, Chen J, Cheng X, Den Z, Ganeshan R, et al. (2013) Plakoglobin as a Regulator of Desmocollin Gene Expression. J Invest Dermatol.
91. Yim JH, Baek JH, Lee CW, Kim MJ, Yun HS, et al. (2013) Identification of HDAC4 as a target of gamma-catenin that regulates the oncogenic K-Ras-mediated malignant phenotype of Rat2 cells. Biochem Biophys Res Commun.
92. Todorovic V, Desai BV, Patterson MJ, Amargo EV, Dubash AD, et al. (2010) Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signaling. J Cell Sci 123: 3576-3586.
93. Ayabe T, Tomita M, Matsuzaki Y, Ninomiya H, Hara M, et al. (2004) Micrometastasis and expression of nm23 messenger RNA of lymph nodes from lung cancer and the postoperative clinical outcome. Ann Thorac Cardiovasc Surg 10: 152-159.
94. Syed V, Mukherjee K, Lyons-Weiler J, Lau KM, Mashima T, et al. (2005) Identification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling. Oncogene 24: 1774-1787.
95. Nakanishi K, Kumaki F, Hiroi S, Mukai M, Ikeda E, et al. (2006) Mre11 expression in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Arch Pathol Lab Med 130: 1330-1334.